TPTX - Turning Point Therapeutics Inc
Previous close
76.01
0 0%
Share volume: 0
Last Updated: Tue 16 Aug 2022 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$76.01
0.00
0.00%
Summary score
45%
Profitability
50%
Dept financing
1%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.85%
Return on assets
-8.7%
Return on sales
0%
Return on invested capital
579.68%
Total debt ratio
4.55%
Debt ratio change over timeo
-0.99%
Current Ratio
34.58%
Quick Ratio
0%
Cash Position Ratio
13.83%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.6%
Return on assets
-7.66%
Return on sales
0%
Return on invested capital
708.11%
Total debt ratio
3.39%
Debt ratio change over timeo
-0.99%
Current Ratio
40.98%
Quick Ratio
0%
Cash Position Ratio
15.48%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-4.43%
Return on assets
-4.51%
Return on sales
0%
Return on invested capital
642.58%
Total debt ratio
2.01%
Debt ratio change over time
-1%
Current Ratio
62.79%
Quick Ratio
0%
Cash Position Ratio
41.1%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.05%
Return on assets
-102.05%
Return on sales
0%
Return on invested capital
63.02%
Total debt ratio
-99.08%
Debt ratio change over time
-0.99%
Current Ratio
7.78%
Quick Ratio
0%
Cash Position Ratio
1.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TPTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -8.85% | 0% | 0% | 29.06% |
| Return on assets | -8.7% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 579.68% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 27% |
| Total debt ratio | 4.55% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.99% | 0% | 0% | 19.02% |
| Dept financing | 1% | 0% | 0% | 50% |
| Current Ratio | 40.98% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 15.48% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 35% |
| Short-term ratios | TPTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -7.6% | 0% | 0% | -16.12% |
| Return on assets | -7.66% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 708.11% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 3% |
| Total debt ratio | 3.39% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.99% | 0% | 0% | 0.09% |
| Dept financing | 1% | 0% | 0% | 50% |
| Current Ratio | 40.98% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 15.48% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 38% |